- Home
- Diabetology
- Evaluating the Efficacy of Linagliptin/Empagliflozin in Type 2 Diabetes: Renal and Glycemic Outcomes

1w3 min read
Medical Article
Introduction Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, progressive β-cell dysfunction, and persistent hyperglycemia (1). Beyond glycemic dysregulation, T2DM contributes significantly to microvascular and macrovascular complications, with diabetic nephropathy (DN) being one of the most serio

Evaluating the Efficacy of Linagliptin/Empagliflozin in Type 2 Diabetes: Renal and Glycemic Outcomes
Similar Content

Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes

Short-term Insulin Therapy for better Glycemic Control
14 Reached5 Comments6 Likes

Autoimmune Hepatitis in Girl with T1DM
1154 Reached2 Comments4 Likes

Risk Factors Associated Glycemia in LBW Infants
2793 Reached2 Comments1 Likes

Link between PCOS, Obesity and Diabetes
479 Reached2 Likes